The document discusses the pharmaceutical industry development process in India. It outlines the legal requirements and licenses needed to manufacture or import APIs and drugs. Companies must seek approval from the DCGI and adhere to CDSCO guidelines. The application process requires submitting chemical, pharmaceutical, pre-clinical and clinical data. Various forms are used for obtaining manufacturing, import, and sales licenses from the CDSCO. The CDSCO-SUGAM project aims to streamline approval processes.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Role of quality system and audits in pharmamaceuticalganpat420
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
Aseptic process tech & advanced sterile product mfg rashmi nasareRASHMINasare
Aseptic process technology & advanced sterile product manufacturing technology it is done for doing in process quality control test for sterile product
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Role of quality system and audits in pharmamaceuticalganpat420
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
Aseptic process tech & advanced sterile product mfg rashmi nasareRASHMINasare
Aseptic process technology & advanced sterile product manufacturing technology it is done for doing in process quality control test for sterile product
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
Qualification of Dissolution Test Apparatus and Validation of Utility System this presentation will help to enhance your knowledge in validation and qualification area.
Autoclave
Principle of Autoclave
Construction of Autoclave
Working of Autoclave
Qualification of Autoclave
Installation Qualification
Operational Qualification
Performance Qualification
References
QUALIFICATION OF MANUFACTURING EQUIPMENTSANKUSH JADHAV
it gives the information about qualification of various manufacturing equipment which is used into the pharmaceutical labs. (only for information purpose)
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms.
This powerpoint presentation includes all the details regarding the topic Drug approval process with special procedure of Drug approval process in India.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
Qualification of Dissolution Test Apparatus and Validation of Utility System this presentation will help to enhance your knowledge in validation and qualification area.
Autoclave
Principle of Autoclave
Construction of Autoclave
Working of Autoclave
Qualification of Autoclave
Installation Qualification
Operational Qualification
Performance Qualification
References
QUALIFICATION OF MANUFACTURING EQUIPMENTSANKUSH JADHAV
it gives the information about qualification of various manufacturing equipment which is used into the pharmaceutical labs. (only for information purpose)
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms.
This powerpoint presentation includes all the details regarding the topic Drug approval process with special procedure of Drug approval process in India.
Indian regulatory requirements - industrial pharmacy 2Jafarali Masi
Indian Regulatory Requirements: Central Drug Standard Control Organization (CDSCO) and State Licensing Authority: Organization, Responsibilities, Certificate of Pharmaceutical Product (COPP), Regulatory requirements and approval procedures for New Drugs
Regulation Governing Clinical Trials In India,USA and Europe. KapilKumar198
This presentation contain detailed information about the "Regulation Governing Clinical Trials In India,USA and Europe".And about the clinical trails and medical devices regulations in India.
IIMPORT AND REGISTRATION AS PER DRUG AND COSMETIC ACT Sagar Savale
The drug and cosmetic act was passed on 10th April, 1940.
Objective : To regulate the import, manufacture, distribution, and sale of Drug and Cosmetics.
All classes of the drugs and cosmetics imported into India, shall comply with the prescribed standards and labels.
Manufacture of all classes of drug require prior license.
a concise yet very informative presentation, on drug approval process and clinical trial regulations in India, prepared for clinical research students
Please refer notes for abbreviations and additional information
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
The Indian economy is classified into different sectors to simplify the analysis and understanding of economic activities. For Class 10, it's essential to grasp the sectors of the Indian economy, understand their characteristics, and recognize their importance. This guide will provide detailed notes on the Sectors of the Indian Economy Class 10, using specific long-tail keywords to enhance comprehension.
For more information, visit-www.vavaclasses.com
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
We all have good and bad thoughts from time to time and situation to situation. We are bombarded daily with spiraling thoughts(both negative and positive) creating all-consuming feel , making us difficult to manage with associated suffering. Good thoughts are like our Mob Signal (Positive thought) amidst noise(negative thought) in the atmosphere. Negative thoughts like noise outweigh positive thoughts. These thoughts often create unwanted confusion, trouble, stress and frustration in our mind as well as chaos in our physical world. Negative thoughts are also known as “distorted thinking”.
Ethnobotany and Ethnopharmacology:
Ethnobotany in herbal drug evaluation,
Impact of Ethnobotany in traditional medicine,
New development in herbals,
Bio-prospecting tools for drug discovery,
Role of Ethnopharmacology in drug evaluation,
Reverse Pharmacology.
The Art Pastor's Guide to Sabbath | Steve ThomasonSteve Thomason
What is the purpose of the Sabbath Law in the Torah. It is interesting to compare how the context of the law shifts from Exodus to Deuteronomy. Who gets to rest, and why?
How to Create Map Views in the Odoo 17 ERPCeline George
The map views are useful for providing a geographical representation of data. They allow users to visualize and analyze the data in a more intuitive manner.
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
Pharmaceutical Industry Development
1. Presented by- Rohit Koli
Guided by- Dr. Sapna Ahirrao
Class- M Pharmacy First Year Sem-II
Subject- Pharmaceutical Manufacturing Technology
Pharmaceutical Industry
Development
2. M. Pharm Sem- II Presentations
Title- Pharmaceutical Industry Development
SUBMITTED TO
SAVITRIBAI PHULE, PUNE UNIVERSITY , PUNE
FOR
PARTIAL FULFILMENT OF REQUIREMENTS FOR THE AWARD OF
MASTER OF PHARMACY
IN THE SUBJECT
Pharmaceutical Manufacturing Technology
IN THE FACULTY OF SCIENCE AND TECHNOLOGY
Bhujbal Knowledge City,
MET’s Institute of Pharmacy,
Adgaon, Nashik, 422003.
Maharashtra, India
Academic Year-2021-22 2
Presented By-
Rohit Koli
Guided By:-
Dr.Sapna Ahirrao
3. Content
• Overview
• Legal requirements and Licences for API and
Formulation industry
• Manufacturing or importing of drugs
• Application and data required
• Licenses for APIs/ Drugs
• CDSCO- Sugam
• Conclusion
• References
3
4. Pharmaceutical Industry Developments
Overview-
• The pharmaceutical industry discovers, develops, produces,
and markets drugs or pharmaceutical drugs for use as
medications to be administered (or self-administered) to
patients, with the aim to cure them, vaccinate them, or
alleviate the symptoms.
• Pharmaceutical companies may deal in generic or brand
medications and medical devices.
• They are subject to a variety of laws and regulations that
govern the patenting, testing, safety, efficacy and marketing of
drugs.
4
5. Legal Requirements and Licenses for API and
Formulation Industry
All new drugs (drugs not previously used in India or in use for less than four
years) proposed to be introduced must be approved for import or manufacture
in India by the DCGI.
The full set of data to be submitted consists of:
• Introduction: description of drug and therapeutic class
• Clinical and pharmaceutical information
• Animal pharmacology
• Animal toxicology
• Human/ clinical pharmacology (Phase I)
• Exploratory clinical trials (Phase II)
• Confirmatory clinical trials (Phase III)
• Special studies Regulatory status in other countries
• Marketing information
5
6. • To manufacture or import Active Pharmaceutical Ingredient
(API)/drugs to India, the company or the organisation should
seek prior approval from Drugs Controller General Of India
(DCGI) for licencing to produce and distribute.
• To produce the drugs, the company should also follow the
norms as stipulated by the Central Drugs Standard Control
Organisation (CDSCO).
• The DCGI and CDSCO will be monitored by the Ministry of
Health and Family Welfare.
• To support DCGI and CDSCO for widening scope and
research, Government of India (GoI) has formed the Drug
Technical Advisory Board (DTAB) and Drug Consultative
Committee (DCC).
6
Manufacturing or importing of Drugs
7. 7
Any new drug that is yet to be introduced into the country should
conduct trails, collect sample data, approval process and adhere
to Appendix 1, IA and VI of Schedule Y and the following rules
as mandated by the Drugs and Cosmetics Act 1940 and Rules
1945:
1. Rule 122 A- Permission to Import new Drugs
2. Rule 122 B- Permission to Manufacture new Drugs
3. Rule 122 DA- Definition of Required clinical trials
4. Rule 122 E- Definition of Drugs
8. 8
The following are the rules and regulations Guidelines
that should be followed By the company to introduce
the new drug in India:-
1. Drugs and Cosmetics Act 1940 and its rules 1945
2. Narcotic Drugs and Psychotropic Substances of 1985
3. Drugs Price Control Order of 1995
4. Protection Act of 1986
5. ICH GCP Guidelines
6. Schedule Y Guidelines
7. ICMR Guidelines
9. Application and Data Required
9
To seek permission to manufacture or import new drugs for
production, marketing or for clinal trials, the company should
attach the following data in Form 44 as stipulated by Schedule Y
(Rules 122A, 122B, 122D, 122DAAAND 122E):
• Chemical and Pharmaceutical details, as mentioned in item 2
of Appendix I
• Data of Animal Pharmacology, as mentioned in item 3 of
Appendix I and Appendix IV
• Actions taken for general pharmacology as prescribed in item
3.3 of Appendix I and item 1.2 of Appendix IV
10. 10
• Pharmacokinetic data with respect to the absorption,
distribution, metabolism and excretion of the test substance as
prescribed in item 3.5 of Appendix I
• Data of Animal Toxicology, as mentioned in item 4 of
Appendix I and Appendix III
• Regulatory Status, as mentioned in item 9.2 of Appendix I
• Details related to marketing new drugs as mentioned in item
10 of Appendix I
• Protocols and methods involved for testing quality, as
mentioned in item 11 of Appendix I
• If the drug involved in the study has to be imported, details
should be furnished in Form
11. Drug approval process in India
11
Applicant
Application to ethical committee
Report of ethical committee
IND Application to CDSCO
Examination by New drug division
Detail review by IND Committee
Recommendation to DCGI
IND Application Approved
Clinical trials started
NDAApplication to CDSCO
Review by DCGI
Refused to grant license License granted
If positive
Within 12 weeks
If not complete If complete
12. Licenses for API/ Drugs
12
Form 27-B: Application for grant or for renewal of
license to manufacture for sale or distribution of drugs
specified in schedule C, C(1) and X.
Form 28-B: License to manufacture for sale or
distribution of drugs specified in schedule C, C(1) and
X.
Form 24-D: Application for grant or for renewal of
license to manufacture for sale or distribution of
Ayurvedic, Siddhaor Unani medicine.
13. • Form 25-D: License to manufacture for sale or
distribution of Ayurvedic, Siddha or Unani
medicine.
• Form 40: submission of application in Form 40
to CDSCO for Registration Certificate and issuing
License for importof drugs into India.A duly filled
Form 40 as per the proforma prescribed in the
Drugs & Cosmetics Rules, signed & stamped by
the (Local Authorized Agent/manufacturer) along
with name & designation and date.
14. 14
Form 19: Application for grant or renewal of a license
to sell, stock, exhibit or offer for sale or distribute Drugs
other than those specified in schedule X.
Form 19 A : Application for grant or renewal of
restricted license stock or exhibit or offer for sale, or
distribute Drug by retail by dealers who do not engage
the service of qualified person.
Form 19 AA: Application for grant or renewal of a
license to sell,stock or exhibit sale by wholesale or
distribute drug from motor vehicle.
15. Joint responsibilities of CDSCO and SLA's
Licensing of Specilised
Products
Vaccines
And
Sera
Blood
And Its
Components
LVPs R-DNA
Products
Medical
Devices
16. CDSCO- SUGAM
• This project has brought simplicity, transparency, reliability,
accountability, timeliness and also simplified ease of business.
• It is the project of national importance that directly reflects the
Governments DIGITAL INDIA initiatives.
Prime Objectives:-
1. To establish single window for multiple stack holders
involved in the process of CDSCO.
2. To consolidate the Indian Drug Regulatory Framework by
streaming the CDSCO processes.
3. To enable paperless grant of various clearances by CDSCO.
17.
18. Registering with CDSCO -
Companies importing drugs should register with
CDSCO in Form 41. The Form shall contain details of
the manufacturing site and drugs used and required.
After furnishing in Form-41, the company can approach
CDSCO for Import Registration Certificate and Import
Licence.
Though registration is not required for clinical tests,
New Drug and Clinical Trial Rules, 2019 states that the
company imports drugs should furnish details in Form
16 for NOC and Test Licence.
18
19. Fees for registration with CDSCO-
• For manufacturers in India, the registration fee is Rs.3,00,000
• For companies importing drugs, the registration fee is USD 1500
• For registering a new drug, the fee is USD 1000 per drug
Validity of the Registration Certificate-
The registration certificate issued by CDSCO is valid for three years
from the date issued.
Renewal of Registration Certificate-
To renew the registration certificate, the company should apply nine
months before the expiry date with all required documents.
19
20. 20
Regulatory
Functions
•Applications
online in the
Clinical Trials
Registry - India
(CTRI)
•Approval of
applications
•Good Clinical
Practices
•Inspections
•Registration of
Ethics
Committee
•Serious
Adverse
Events(SAE)
•12 Subject
Expert
Committees
(SECS) for
deliberation on
new drug
applications for
grant of
marketing
licence
•Import of new
drugs
(Registration of
foreign
manufacturer s
and grant of
licence to
import)
Application for
Licence to
manufacture
•Inspection of
Good
Manufacturing
Practices (WHO
GMP/Schedule
M)
• Grant of
Licence to
Manufacture
• Collection of
Samples, testing
and prosecution
for Non
Compliance
•Application for
Licence to
distribute and
sell
•Inspection of
Good
Distribution
Practices(GDP)
and sale
premises
•Grant of
Licence to
distribute and
sell
•Prosecution for
Non
Compliance
•Periodic Safety
Update Reports
(PSURS)
required to be
submitted for
new drugs
granted
marketing
licence
•Banning of
Drugs
considered
harmful or sub
therapeutic
•Pharmacovigila
nce Programme
of India (PvPI)
STAGES CLINICAL
TRIALS
NEW DRUG
APPROVALS
MANUFACTU
RING
DISTRIBUTION
AND SALES
POST
MARKETING
SURVEILLANCE
Pre Manufacturing Manufacturing
Distribution
And sale Post marketing
21. 21
Authority
Responsible
CDSCO
(appointed by
the MOHFW,
Central
Government.)
has the sole
responsibility -
relies on expert
committees.
CDSCO has the
sole
responsibility.
SDRA
(appointed by
the Department
of Health, State
Government)
has primary
responsibility.
Exceptions
(CDSCO
competence)-
•CDSCO acts as
SDRA in Union
Territories (e.g.
Delhi)
•WHO-GMP
Inspections
•High Risk
Products
(CDSCO may
include new
products in this
list via
notification)
SDRA has the
Sole
Responsibility.
CDSCO has
sole
responsibility
for PSURs and
Indian
Pharmacopoeia
Commission
(IPC) is in
charge of co-
ordinating
Adverse Drug
Reports (ADRs)
22. Conclusion
• The pharmaceutical company which has proposed to introduce
a new drug in the market must comply with all the legal
requirements and must acquire all the licenses needed to
introduce the drug in the market by following all the rules and
regulation’s guidelines.
• The purpose of drug registration is to guard the general public
health and not to facilitate profit of pharmaceutical
manufacturers.
• Registration should be seen as a critical step in ensuring access
to safe and effective medicinal products.